If youve followed a standard titration schedule and continue to experience side effects that interfere with daily life, a slower increase or a temporary hold at your current dose might help
For GLP-1 users, what makes Cronometer particularly valuable is the micronutrient visibility
Even after approval, availability may depend on labeling, supply, prescriber adoption, and payer decisions
If the FDA approves tirzepatide for a new indication that is not weight loss (for example, cardiovascular risk reduction, sleep apnea, or fatty liver disease), and that indication is not explicitly excluded by statute, TRICARE could cover tirzepatide for that indication
Muskiet has served as a consultant and speaker for Eli Lilly & Co, Novo Nordisk, and Sanofi, and all honoraria are paid to the Amsterdam University Medical Centers (location VUMC), Amsterdam, the Netherlands